[Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
作者信息
Naruszewicz M, Nowicka G, Szostak W B, Kłosiewicz-Latoszek L
出版信息
Kardiol Pol. 1982;25(7-8):527-31.
PMID:7169740
Abstract
摘要
相似文献
1
2
[Plafibride treatment of hyperlipidemias type II and IV].[普拉纤维蛋白原治疗II型和IV型高脂血症]
Med Clin (Barc). 1984 May 19;82(19):840-2.
3
[A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].苯扎贝特与氯贝丁酯治疗ⅡB型和Ⅳ型高脂蛋白血症的比较
Acta Med Austriaca. 1979;6(3):90-4.
4
5
[Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].[苯扎贝特与非诺贝特对IIa型、IIb型及IV型高脂蛋白血症血脂升高的疗效]
Med Welt. 1982 Apr 30;33(17):631-7.
6
[The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].[苯扎贝特对各型高脂蛋白血症的治疗效果]
Schweiz Med Wochenschr. 1980 Dec 6;110(49):1875-7.
7
Clinical experience with bezafibrate.苯扎贝特的临床经验。
Artery. 1980;8(6):553-9.
8
Effects of bezafibrate on the composition of very low density lipoproteins in type IV hyperlipoproteinemia.
Atherosclerosis. 1982 Apr;42(2-3):245-9. doi: 10.1016/0021-9150(82)90154-x.
9
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
Artery. 1980;8(6):537-46.
10
The effect of etofibrate retard, bezafibrate and procetofen.益多酯缓释剂、苯扎贝特和普西托芬的作用。
Artery. 1980;8(2):128-33.
Zotero 插件